Research Paper Volume 13, Issue 13 pp 17914—17929

Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis


Figure 3. Roxadustat effect on Hb change. Forest plots for the subgroup of (A) High dose in NDD (B) Low dose in NDD. (C) High dose in DD. (D) Low dose in DD. In the NDD studies the control was placebo, and in the DD studies the control was EA or ESA.